We describe the lipoprotein and apolipoprotein profiles and their relationship to cardiovascular risk factors in Australian Aboriginal children. This cross-sectional study within a longitudinal birth cohort study involved Australian Aboriginal children born between 1987 and 1990 and re-examined between 1998 and 2001. Height, weight, blood pressure, waist circumference, body fat percentage, cholesterol, triglycerides, HDL-c, LDL-c, apolipoprotein B and A1 were measured. Mean age was 11.4 years (52% male). Mean cholesterol, triglyceride, HDL-c and LDL-c did not differ from reference data. Measures of obesity, blood pressure and prevalence of the metabolic syndrome did not differ in those children with lipoproteins in the upper quartile of the cohort (lower quartile for HDL-c). Boys with an Apo-B/A1 ratio in the upper quartile of the cohort had higher BMI z-score, waist z-score, % body fat, diastolic blood pressure and frequency of the metabolic syndrome (p<0.05). In girls, waist circumference, % body fat and the prevalence of the metabolic syndrome was higher in those with an Apo-B/A1 ratio in the upper quartile (p<0.05). The Apo-B/A1 ratio may be useful to identify cardiovascular risk in Australian Aboriginal children and is suited to clinical practice as the assays are standardised, accurate, automated and a fasting sample is not required.
Introduction
The prevalence of CVD in the Aboriginal people of the Northern Territory of Australia is high and has increased over the last three decades. 1 Dyslipidaemia is a major independent risk factor for CVD 2 and is frequent in the adult Australian Aboriginal population including those less than 30 years of age. 3, 4 CVD risk is directly related to the number of circulating atherogenic particles that contact and enter the vascular wall. 5 Apo-B represents the best estimate of total atherogenic particle number. 5 In adults, Apoliprotein (Apo-B) has been shown to be superior to LDL-c in predicting vascular events, the progression of vascular disease and response to statin therapy. 6 The use of LDL-c is further compromised as LDL-c calculations can be problematic when triglyceride levels are elevated above 2.5 mmol/L. 7 The lipoprotein-related risk of vascular disease risk is primarily determined by the balance between proatherogenic particles (containing Apo-B) and anti-atherogenic particles (containing apolipoprotein A1 or Apo-A1). In adults, the Apo-B/A1 ratio has been shown to be the strongest single lipoprotein-related atherosclerotic risk factor. 6 Risk prediction does not improve by adding any other lipid indices or cholesterol ratios. 6 The INTERHEART Study, a case-control study with more than 15,000 cases from 52 countries, confirmed the predictive value of the Apo-B/A1 ratio across all geographic regions, gender, ethnic groups and the age spectrum within the adult population. 8 This single index accounted for greater than 50% of the cardiovascular events in this study. 8 The atherosclerotic process begins early in life. Aortic and coronary artery intimal lesions have been identified in late adolescence. 9 Detection of dyslipidaemia at an early age before clinical manifestations of disease are apparent is fundamental to early intervention and development of primary prevention strategies for CVD in populations at risk. For early intervention to occur, an understanding of the most sensitive risk indicators for early CVD is essential.
There is little data regarding lipoprotein and apolipoprotein levels in Australian Aboriginal children and youth, a population at risk for significant cardiovascular morbidity and mortality in early adult years. The objective of this study was to describe the lipoprotein and apolipoprotein profiles and their relationship to cardiovascular risk factors in Australian Aboriginal children.
Methods
The ABC was established between January 1987 and March 1990. Details of the study population, methods and laboratory techniques have been previously reported. 10 A summary of the key points follows.
Study population
Six hundred and eighty-six of 1238 Aboriginal children born at the Royal Darwin Hospital between January 1987 and March 1990 were recruited into this cohort. There were no significant differences in the mean birth weight, birth weight frequencies or sex ratio between those recruited and not recruited. 10 The Royal Darwin Hospital is the designated hospital for routine newborn delivery within the Darwin Health Region. Deliveries of mothers from outside this region are on a referral basis. This paper is restricted to discussion of children from the Darwin Health Region (570/686 of the original cohort).
Study visit
Each participant was assessed at a single visit between December 1998 and March 2001. The following cardiovascular risk factors were assessed: blood pressure, BMI and % body fat (estimates of total body adiposity), waist circumference (a marker of central adiposity) and presence of the metabolic syndrome (a clustering of CVD risk factors).
Children were measured in light clothing while barefoot. Height was measured to the nearest millimetre with a portable stadiometer. Weight was measured to the nearest 0.1 kg with a digital electronic scale (TBF-521, Tanita Corporation, Illinois, USA). Body mass index (BMI kg/ m 2 ) was expressed as BMI z-score for analysis. Sitting blood pressure was measured using an automatic unit (Lifesigns BP Monitor, Welch Allyn, New York, USA). Percent body fat was measured using bio-electrical impedance analysis (TBF-521, Tanita Corporation, Illinois, USA). Waist circumference was measured at the midpoint between the lowest rib and iliac crest along the midaxillary line at the end of expiration. Children were asked to fast from midnight and blood samples were taken in the morning after application of a topical anaesthetic cream (EMLA ® ). Breakfast was provided following the study visit.
Definitions
Published paediatric lipoprotein 11 and apolipoprotein 12 standards were used for the reference population. These standards for ages 4-19 years were derived from a large mixed ethnic American population in the NHANES III survey. The reference population for the Apo-B/A1 ratio was derived from a large US cohort that included significant numbers within the paediatric age group. 13 A single group mean was used for each element of the lipid profile, as the variation between gender and age groups is minimal with the exception of Apo-A1 and the Apo-B/A1 ratio. 11 Gender-specific means are presented for Apo-A1 and Apo-B/A1 ratio. The technology used in the reference populations was comparable to that used in this study.
A paediatric definition modified from the National Cholesterol Education Program was used to define the metabolic syndrome. 14 Waist z-score and BMI z-scores were derived from published paediatric reference data. 15, 16 There are no Australian or population-specific reference data available generated using similar measurement techniques. 
Laboratory analysis

Ethics
The Joint Institutional Ethics Committee of the Royal Darwin Hospital and the Menzies School of Health Research, including the Aboriginal Ethical Sub-committee, approved the study. Written consent was obtained from the caregivers of all children.
Statistical analysis
Descriptive statistics were expressed as means and 95% confidence intervals. Unpaired t-tests were used to compare means between groups for continuous variables. A two-tailed chi-square or the Fisher's Exact Test was used to compare categorical variables. All analyses were conducted using Stata™ 9.0 software (StataCorp, Texas, USA 2006). Statistical significance for all testing was accepted at p<0.05.
Data for the reference population values for the Apo-B/ A1 ratio are available only in terms of median values. As the sample distribution of the median can be difficult to determine, determining the confidence intervals and significance testing for compatibility of this variable with the reference population was carried out using the bootstrap method. 17 The relationship between apolipoproteins and cardiovascular risk factors was examined within the cohort by dividing the cohort into the upper versus the lower three quartiles for total cholesterol, triglycerides, LDL-c, Apo-B and Apo-B/A1 ratio and by the lower quartile versus upper three quartiles for HDL-c and Apo-A1.
Results
Four hundred and eighty-nine of the original cohort of 570 (86%) were seen at follow-up. The remaining children either could not be traced or, for logistic reasons, were not available for re-examination at the time of study follow-up.
Mean age of the cohort participants was 11.4 years (range 8.9-13.8 years). Fifty-two per cent were boys. A fasting lipid profile (total cholesterol, triglycerides, HDL-c and LDL-c) was available on 286 participants (59%). Apo-B and Apo-A1 were available on 385 (79%) and 332 (68%) participants respectively. There were no significant differences for mean age, BMI z-score, waist circumference z-score, birth weight, gestational age or gender distribution between those who had fasting blood work and those who did not.
The mean triglyceride and LDL-c did not differ significantly between the cohort participants and the reference population. Total cholesterol and HDL-c of cohort participants was significantly lower (table 1). The percentage of participants who had a total cholesterol, LDL-c, or triglyceride level exceeding the 75th centile or an HDL-c <25th centile of the reference population did not differ significantly from the expected 25% for each variable. Mean Apo-B and Apo-A1 were significantly lower, and the median Apo-B/A1 ratio significantly higher, compared with the reference populations (table 1) .
Mean BMI z-score, waist circumference z-score, systolic blood pressure, diastolic blood pressure, % body fat and prevalence of metabolic syndrome did not differ significantly between participants with cholesterol, triglycerides or LDL-c in the upper quartile of the cohort compared with those in the lower quartiles. The BMI z-score, waist circumference z-score, systolic blood pressure, diastolic blood pressure and % body fat did not differ between children with non-HDL-c/HDL-c ratio in the upper quartile compared with those in the lower quartiles. The prevalence of the metabolic syndrome was significantly higher in both boys and girls with a non-HDL-c/HDL-c ratio in the upper compared to in the lower quartiles. There were also no significant differences for these CVD risk factors for those in the lowest quartile for HDL-c compared with the upper quartiles.
The mean Apo-B/A1 ratio of those with triglycerides in the upper quartile of the population did not differ significantly from the mean Apo-B/A1 ratio of those with triglycerides in the lower quartiles. In contrast, the mean non-HDL-c/HDL-c ratio in those with triglycerides in the upper quartile of the population was significantly higher than the mean non-HDL-c/HDL-c ratio in those with triglycerides in the lower quartiles. However, neither triglycerides nor non-HDL-c/HDL-c ratio identified cardiovascular risk (noted above).
Male participants with Apo-B/A1 ratio in the upper quartile of the cohort had significantly higher levels of adiposity (both central and total as measured by waist circumference, BMI and % body fat), higher diastolic blood pressure and increased frequency of the metabolic syndrome (table 2). In girls, those with an Apo-B/A1 ratio in the upper quartile of the cohort had significantly larger waist circumferences, % body fat and presence of the metabolic syndrome. A non-significant trend for increased BMI was also seen. A non-significant trend was seen for a higher mean Apo-B/A1 ratio in both boys and girls with the metabolic syndrome compared with those without. 
Discussion
In this paper we described the lipoprotein and apolipoprotein profile in a cohort of Australian Aboriginal children, a population at risk for early CVD. The traditional lipoprotein profile (total cholesterol, triglycerides, HDL-c and LDL-c) did not discriminate those children with CVD risk factors. In contrast, apolipoprotein levels differed significantly from the reference population and the Apo-B/A1 ratio identified those children, particularly boys, with CVD risk factors. Importantly, apolipoproteins have significant practical advantages for clinical use. They do not require a fasting sample and use standardised assays that are accurate and automated. 7 The literature related to Apo-B/A1 ratio in the paediatric years is limited, although several studies have demonstrated an increased Apo-B/A1 ratio in children with a family history of early cardiovascular disease. [18] [19] [20] In a cross-sectional study of Canadian Aboriginal children, both Apo-B and the Apo-B/A1 ratio increased as the number of components of the metabolic syndrome increased. 21 This population is also at risk for early CVD. The mean Apo-B/A1 ratio in boys and girls in this population did not differ significantly from our population (0.58 in boys; 0.63 in girls; p>0.05). However, in the Canadian Aboriginal population, the increased Apo-B/A1 ratio resulted primarily from an increase in proatherogenic Apo-B levels. This is in contrast to our population of Australian Aboriginal children, where the balance between atherogenic and anti-atherogenic particles is disrupted primarily because of decreased anti-atherogenic Apo-A1 levels. Similarly, adult Australian Aboriginal populations have low HDL-c levels. 4, 22 Apo-A1 has been shown to be protective against CVD. This protective effect is lost as Apo-A1 decreases. 23 An understanding of the primary disruption of this balance is of importance as it directs the appropriate therapeutic intervention. 24 High rates of obesity (defined as a BMI ≥95 th percentile for age and gender) have been described in Canadian Aboriginal children. 25 This is in contrast to this population of Australian Aboriginal children who have low rates of obesity but a high frequency of elevated waist circumference. 26 The Australian Aboriginal adult has a relatively low sitting height-to-stature ratio which may contribute to the lower BMI found in this population. 27 These anthropometric differences may, in part, explain the differences observed in apolipoprotein indices.
The rate of CVD increases in the Australian indigenous population 10 years earlier than in the non-indigenous population, and almost two times as many indigenous people report cardiovascular disease compared with the non-indigenous Australian population in the 35-44 years age range. 28 Our findings suggest that increased cardiovascular risk is already present in this young cohort and can be identified by an increased Apo-B/A1 ratio.
The use of reference standards derived from other populations may be problematic as they may not reflect the 'true' normal range in the population to which they are applied. However, the presence of early CVD in the Australian Aboriginal population suggests that the low Apo-A1 and high Apo-B/A1 ratio found in this study are of clinical importance. Long-term follow-up of this cohort may help establish population-specific norms based on risk of cardiovascular events.
In summary, the Apo-B/A1 ratio may be useful to identify cardiovascular risk in Australian Aboriginal children. These apolipoproteins are well suited to clinical practice as the assays are standardised, accurate and automated, and do not require a fasting sample.
